
Health In Tech, Inc.: updates and filings
Price
$0.38
November 18, 2026Market cap $21M
What Ploutos Investor adds for Health In Tech
Part of Ploutos Investor, €9.99 a month
- The full history: 3 fiscal years, from 2023
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 13, 2026next Feb 12, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
- 18WedPeopleOfficer or director change, Regulation FD disclosureDocument
- 13FriReportQuarterly report · for the period to Sep 30, 2026Document
- 13FriResultsResults of operations, Regulation FD disclosureDocument
- 12ThuShareholdersShareholder voteDocument
- 6FriDealMaterial agreement entered, new material financial obligationDocument
October 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 18, 2026Officer or director change, Regulation FD disclosureForm8-K
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 13, 2026Regulation FD disclosureForm8-K
- Nov 13, 2026Regulation FD disclosureForm8-K
- Nov 13, 2026Results of operations, Regulation FD disclosureForm8-K
- Nov 12, 2026Shareholder voteForm8-K
- Nov 6, 2026Material agreement entered, new material financial obligationForm8-K
- Oct 28, 2026Additional annual meeting materialFormDEFA14A
- Oct 26, 2026Officer or director change, Regulation FD disclosureForm8-K
- Oct 16, 2026Delisting noticeForm8-K
- Oct 15, 2026FilingFormEFFECT
- Oct 13, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Oct 13, 2026Annual meeting proxy statementFormDEF 14A
- Oct 13, 2026Shelf registration for future offerings (amendment)FormS-3/A
- Oct 1, 2026Preliminary proxy statementFormPRE 14A
- Sep 30, 2026Regulation FD disclosureForm8-K
- Sep 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Sep 4, 2026Shelf registration for future offeringsFormS-3
- Aug 13, 2026Regulation FD disclosureForm8-K
- Aug 13, 2026Regulation FD disclosureForm8-K
- Aug 13, 2026Results of operations, Regulation FD disclosureForm8-K
- Aug 13, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 22, 2026FilingFormEFFECT
- Jun 26, 2026Shelf registration for future offerings (amendment)FormS-3/A
- Jun 10, 2026Shelf registration for future offeringsFormS-3
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 18, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Nov 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Nov 13, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Nov 12, 2026 | 8-K | Shareholder vote | Document |
| Nov 6, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| Oct 28, 2026 | DEFA14A | Additional annual meeting material | Document |
| Oct 26, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Oct 16, 2026 | 8-K | Delisting notice | Document |
| Oct 15, 2026 | EFFECT | Filing | Document |
| Oct 13, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Oct 13, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Oct 13, 2026 | S-3/A | Shelf registration for future offerings (amendment) | Document |
| Oct 1, 2026 | PRE 14A | Preliminary proxy statement | Document |
| Sep 30, 2026 | 8-K | Regulation FD disclosure | Document |
| Sep 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Sep 4, 2026 | S-3 | Shelf registration for future offerings | Document |
| Aug 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 13, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 13, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 22, 2026 | EFFECT | Filing | Document |
| Jun 26, 2026 | S-3/A | Shelf registration for future offerings (amendment) | Document |
| Jun 10, 2026 | S-3 | Shelf registration for future offerings | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Apr 19, 2024.
The full analysis
What do Health In Tech's filings show?
The filings are where every one of Health In Tech's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.